Decibel Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Decibel Therapeutics has a total shareholder equity of $53.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $94.4M and $41.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$78.30m |
| Equity | US$53.31m |
| Total liabilities | US$41.08m |
| Total assets | US$94.39m |
Recent financial health updates
Here's Why We're Watching Decibel Therapeutics' (NASDAQ:DBTX) Cash Burn Situation
Aug 10
Is Decibel Therapeutics (NASDAQ:DBTX) In A Good Position To Deliver On Growth Plans?
Feb 07We Think Decibel Therapeutics (NASDAQ:DBTX) Needs To Drive Business Growth Carefully
Sep 01Recent updates
Here's Why We're Watching Decibel Therapeutics' (NASDAQ:DBTX) Cash Burn Situation
Aug 10Is Decibel Therapeutics (NASDAQ:DBTX) In A Good Position To Deliver On Growth Plans?
Feb 07Decibel stock surges 18% as FDA clears hearing loss gene therapy to enter trial
Oct 17We Think Decibel Therapeutics (NASDAQ:DBTX) Needs To Drive Business Growth Carefully
Sep 01Decibel Therapeutics: Gene Therapies For Hearing Loss
Jul 06Financial Position Analysis
Short Term Liabilities: DBTX's short term assets ($80.4M) exceed its short term liabilities ($26.6M).
Long Term Liabilities: DBTX's short term assets ($80.4M) exceed its long term liabilities ($14.5M).
Debt to Equity History and Analysis
Debt Level: DBTX is debt free.
Reducing Debt: DBTX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DBTX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: DBTX has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 9.7% each year.